LILRA5 Antikörper (PE)
Kurzübersicht für LILRA5 Antikörper (PE) (ABIN1830393)
Target
Alle LILRA5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human LILRA5.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
Recombinant corresponding to human LILRA5 expressed in CHO cell line.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
-
Approved: Flo
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Saline, 0.5 % BSA, 0.1 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze. Protect from light.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for at least 1 year at 4°C. Freezing will result in loss of activity. PE conjugates are sensitive to light.
-
-
- LILRA5 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 5 (LILRA5))
-
Andere Bezeichnung
- LILRA5
-
Hintergrund
-
Name/Gene ID: LILRA5
Family: Immunoglobulin
Synonyms: LILRA5, CD85, CD85F, CD85f antigen, ILT-11, ILT11, LILRB7, Leukocyte Ig-like receptor 9, LIR-9, LIR9 -
Gen-ID
- 353514
-
UniProt
- A6NI73
Target
-